Back

Institute for Advanced Medical Education

  • Anticoagulants
  • Atrial Fibrillation
  • Stroke

Balancing Risks and Benefits: Anticoagulation and Antiplatelet Therapy in Stroke Prevention in AFIB, Navigating Dual and Triple Therapies

This course provides an in-depth exploration of the complex considerations involved in managing stroke prevention in patients with atrial fibrillation (AFIB) through anticoagulation and antiplatelet therapy. It delves into the risks and benefits of dual and triple therapy regimens, addressing the challenges of balancing stroke prevention against the potential for bleeding complications. The course includes discussions on patient stratification, risk assessment tools, and the latest evidence-based guidelines. Practical approaches for navigating therapy choices in diverse patient populations, including those with coexisting cardiovascular conditions or prior thrombotic events, are also presented. Through case studies and expert insights, participants will gain a nuanced understanding of tailoring treatment plans to optimize patient outcomes.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 1 credit

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Membership pricing — $199 / year

This provider prices CME through membership. Individual courses may also be sold separately.

Unlimited Plus CME Membership$199/yr
Lifetime CME (Physician)$1,150
Lifetime Physicians CME Membership$1,150

Free membership available for some groups

See plans on iame.com

Listed by the provider · iame.com

  • Case-based learning
  • Credit · Up to 1 credit
  • Membership pricing
  • Released
    Jun 21, 2024
  • Last day to claim credit
    Jun 21, 2027 8 months left